• Mashup Score: 3

    The good news about prescription drugs, in the context of medical spending in the U.S., is that 9 in 10 medicines prescribed are generics. They comprise only 3% of all U.S. healthcare spending.           But there’s bad news about prescription drugs in the context of medical spending in America. U.S. Consumers Overpay for Generic Drugs, a new paper from the Leonard Schaeffer Center for Health…

    Tweet Tweets with this article
    • What if @Costco designed the US #prescriptiondrugs pricing/selling model? https://t.co/y2XOLbLDp4 @USC @SchaefferCenter team analyzed #Medicare data finding Americans overpay for #prescriptiondrugs vs Costco pricing for 184 generics #healtheconomics #retailhealth #drugcosts https://t.co/qMTZVAZy7V

  • Mashup Score: 0

    Shannon Westin, Veena Shankaran, and Scott Ramsey discuss the issue of financial toxicity among low- and middle-income cancer patients.   TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Westin: Welcome to JCO After Hours. I am your fearless leader, Shannon Westin, the editor for social media of the Journal of Clinical Oncology, and it’s my great pleasure to bring…

    Tweet Tweets with this article
    • 🎧 In this #JCO After Hours Podcast w @ShannonWestin, learn about the trifecta of #financialtoxicity from @ShankaranVeena & @ScottDRamsey:  💵 Material 🥺 Behavioral 😩 Psychosocial Listen ➡️ https://t.co/14hGKWizz2 #healtheconomics https://t.co/e6GPEUK4Af

  • Mashup Score: 2

    Endocrine-disrupting chemicals (EDCs) substantially cost society as a result of increases in disease and disability but—unlike other toxicant classes such as carcinogens—have yet to be codified into regulations as a hazard category. This Series paper examines economic, regulatory, and policy approaches to limit human EDC exposures and describes potential improvements. In the EU, general…

    Tweet Tweets with this article
    • Endocrine-disrupting chemicals: economic, regulatory, and policy implications https://t.co/sHA7okP7E3 #EDCs #HealthEconomics #HealthPolicy #Regulatory #FREE to read with registration (also FREE) https://t.co/wMSh5Jo9S2

  • Mashup Score: 17
    BMJ Medicine: 1 (1) - 2 year(s) ago

    September 2021 – Volume 1 – 1 Original research Severity of maternal infection and perinatal outcomes during periods of SARS-CoV-2 wildtype, alpha, and…

    Tweet Tweets with this article
    • RT @BMJMedicine: Latest articles in @BMJMedicine now online ➡️ https://t.co/bMT9ZQrv98 #COVID19, #HealthEconomics, #MedData & more from @…

  • Mashup Score: 47
    BMJ Medicine: 1 (1) - 2 year(s) ago

    September 2021 – Volume 1 – 1 Original research Severity of maternal infection and perinatal outcomes during periods of SARS-CoV-2 wildtype, alpha, and…

    Tweet Tweets with this article
    • RT @BMJMedicine: Latest articles in @BMJMedicine now online ➡️ https://t.co/bMT9ZQrv98 #COVID19, #HealthEconomics, #MedData & more from @…

    • RT @BMJMedicine: Latest articles in @BMJMedicine now online ➡️ https://t.co/bMT9ZQrv98 #COVID19, #HealthEconomics, #MedData & more from @…

    • RT @BMJMedicine: Latest articles in @BMJMedicine now online ➡️ https://t.co/bMT9ZQrv98 #COVID19, #HealthEconomics, #MedData & more from @…